It’s not just its new V4 engine that CFMoto has unveiled at the 2024 Esposizione Internazionale Ciclo Motociclo e Accessori ...

Initial Clinical Data from Phase 1 Autoimmunity Study of FT819 1XX CAR T-cell Product Candidate to be Presented in 4Q24; Second Treatment Arm ...

Maura Higgins wowed in a leggy tweed mini dress as she headed for lunch at Claridge's in London with her pal Olivia Attwood ...

BG-T187 (EGFR x MET trispecific antibody): Initiated dose escalation; EGFR and MET dual targeting to address large ...

Russia proposes supplying India with its advanced Tu-160M strategic bombers, enhancing India's air power and long-range ...

Christmas and Jo Malone go hand in hand, with the scents of seasonal colognes (this year, fir and artemisia) filling the air.

CFMoto has rolled off the covers on its new 125NK naked bike which debuted at EICMA alongside its big brother, the 675NK ...

Preclinical data demonstrated durable immune responses and tumor growth inhibition with Mural's IL-18 variants, reinforcing ...

Q3 2024 Earnings Call Transcript November 8, 2024 Y-mAbs Therapeutics, Inc. reports earnings inline with expectations.

BioSpace takes a look at the headlines across a heavy earnings week for biotechs, checking in on Allogene, Rapport and more.

This includes data relating to our enhanced Allo-Evasion™ via a novel CD300a TASR that demonstrated universal protection from NK cells, advanced CAR endo-domains that improve cytotoxicity and ...

Aptevo Therapeutics and Alligator Bioscience report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, more than half of evaluable patients achieved stable diseaseColon ...